Astec Lifesciences gets revision in credit ratings

From ICRA

Astec Lifesciences has received revision in credit ratings from ICRA.

On long term scale - ICRA A-/ Stable (Revised from ICRA BBB)

On short term scale - ICRA A2+ (Revised from ICRA A3+)

Powered by Capital Market - Live News